COVID-19
J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen
November 16, 2020Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine
November 13, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel
Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …
Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role
November 13, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma
Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data
November 12, 2020Sales and Marketing COVID-19, Pfizer, Vaccine, pharma
With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …
First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine
November 11, 2020Research and Development COVID-19, Russia, Sputnik V, Vaccine
The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …
CureVac’s COVID-19 vaccine generates immune responses at Phase 1
November 11, 2020Research and Development COVID-19, CureVac, pharma
German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …
Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis
November 10, 2020Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni
November 9, 2020Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine
AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund
November 9, 2020Sales and Marketing COVID, COVID-19, vaccines
Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …
Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patients
November 6, 2020Medical Communications, Research and Development COVID-19, Novatis, canakinumab
Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to …
Pharmafile.com’s weekly COVID-19 news round-up
November 6, 2020Medical Communications COVID, COVID-19, EC, FDA, coronavirus
The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …
Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech
November 5, 2020Manufacturing and Production Australia, COVID-19, Vaccine
Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …
Pharmafile.com’s weekly COVID-19 news round-up
November 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir
As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan
October 29, 2020Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine
Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative
October 28, 2020Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi
Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
